Sort by

Send to

Choose Destination

Search results

Items: 14


Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.

Posch C, Moslehi H, Sanlorenzo M, Green G, Vujic I, Panzer-Grümayer R, Rappersberger K, Ortiz-Urda S.

Oncotarget. 2016 Jun 14. doi: 10.18632/oncotarget.10001. [Epub ahead of print]


Inhibitory KIR3DL1 alleles are associated with psoriasis.

Ahn RS, Moslehi H, Martin MP, Abad-Santos M, Bowcock AM, Carrington M, Liao W.

Br J Dermatol. 2016 Feb;174(2):449-51. doi: 10.1111/bjd.14081. No abstract available.


Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes.

Zheng CL, Wang NJ, Chung J, Moslehi H, Sanborn JZ, Hur JS, Collisson EA, Vemula SS, Naujokas A, Chiotti KE, Cheng JB, Fassihi H, Blumberg AJ, Bailey CV, Fudem GM, Mihm FG, Cunningham BB, Neuhaus IM, Liao W, Oh DH, Cleaver JE, LeBoit PE, Costello JF, Lehmann AR, Gray JW, Spellman PT, Arron ST, Huh N, Purdom E, Cho RJ.

Cell Rep. 2014 Nov 20;9(4):1228-34. doi: 10.1016/j.celrep.2014.10.031.


Different Anatomical Distribution of Basal Cell Carcinoma Subtypes in Iranian Population: Association between Site and Subtype.

Ghanadan A, Abdollahi P, Rabet M, Naraghi Z, Abbasi MA, Moslehi H, Abbasi A.

Ann Dermatol. 2014 Oct;26(5):559-63. doi: 10.5021/ad.2014.26.5.559.


Dermoscopy of angioma serpiginosum: a case report.

Ghanadan A, Kamyab-Hesari K, Moslehi H, Abasi A.

Int J Dermatol. 2014 Dec;53(12):1505-7. doi: 10.1111/j.1365-4632.2012.05805.x. No abstract available.


Tonsillectomy as a treatment for psoriasis: a review.

Wu W, Debbaneh M, Moslehi H, Koo J, Liao W.

J Dermatolog Treat. 2014 Dec;25(6):482-6. doi: 10.3109/09546634.2013.848258. Review.


Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo.

Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V, Chong K, Peng L, Dimon MT, Phillips T, Daud AI, McCalmont TH, LeBoit PE, Ortiz-Urda S.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4015-20. doi: 10.1073/pnas.1216013110.


Description of some dermatoscopic features of acral pigmented lesions in Iranian patients: a preliminary study.

Ahmadabad RN, Ghaninezhad H, Moslehi H, Azizahari S, Kamyab K, Nikoo A.

Acta Med Iran. 2011;49(7):472-7.


Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features.

Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, Modarressi MH.

Br J Dermatol. 2010 Apr;162(4):772-9. doi: 10.1111/j.1365-2133.2009.09568.x.


Subcision in acne scar with and without subdermal implant: a clinical trial.

Balighi K, Robati RM, Moslehi H, Robati AM.

J Eur Acad Dermatol Venereol. 2008 Jun;22(6):707-11. doi: 10.1111/j.1468-3083.2008.02583.x.


Primary cutaneous actinomycosis of the elbow with an exceptionally long incubation period.

Ghaninejad H, Hasibi M, Moslehi H, Hashemi P, Rashidi A.

Int J Dermatol. 2008 Mar;47(3):304-5. doi: 10.1111/j.1365-4632.2008.03217.x. No abstract available.


Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

Nassif A, Bensussan A, Boumsell L, Deniaud A, Moslehi H, Wolkenstein P, Bagot M, Roujeau JC.

J Allergy Clin Immunol. 2004 Nov;114(5):1209-15.


Tongue lesions in psoriasis: a controlled study.

Daneshpazhooh M, Moslehi H, Akhyani M, Etesami M.

BMC Dermatol. 2004 Nov 4;4(1):16.


Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

Nassif A, Moslehi H, Le Gouvello S, Bagot M, Lyonnet L, Michel L, Boumsell L, Bensussan A, Roujeau JC.

J Invest Dermatol. 2004 Nov;123(5):850-5.

Items per page

Supplemental Content

Loading ...
Support Center